MGX
Metagenomi Therapeutics, Inc.Company with tickers: MGX
CIK
1785279
CUSIP
59102M104
Shares Outstanding
37,646,858
13F Activity (30d)
48 filings
48 filers
| Type | Filing Date | Period | Action |
|---|---|---|---|
| 8-K | 2026-05-11 | — | View |
| 10-Q | 2026-05-11 | 2026-03-31 | View |
| 8-K | 2026-03-05 | — | View |
| 10-K | 2026-03-05 | 2025-12-31 | View |
| 8-K | 2026-01-12 | — | View |
| 8-K | 2025-11-12 | 2025-11-11 | View |
| 10-Q | 2025-11-12 | 2025-09-30 | View |
| 8-K | 2025-10-01 | 2025-09-29 | View |
| 8-K | 2025-08-12 | — | View |
| 10-Q | 2025-08-12 | 2025-06-30 | View |
| 8-K | 2025-06-11 | 2025-06-10 | View |
| 8-K | 2025-05-14 | — | View |
| 10-Q | 2025-05-13 | 2025-03-31 | View |
| 8-K | 2025-05-13 | — | View |
| 8-K | 2025-03-17 | — | View |
| 10-K | 2025-03-17 | 2024-12-31 | View |
| 8-K | 2025-01-16 | 2025-01-13 | View |
| 8-K | 2024-12-10 | 2024-12-09 | View |
| 8-K | 2024-11-13 | — | View |
| 10-Q | 2024-11-13 | 2024-09-30 | View |
| 8-K | 2024-09-03 | — | View |
| 10-Q | 2024-08-14 | 2024-06-30 | View |
| 8-K | 2024-08-14 | — | View |
| 10-Q | 2024-05-14 | 2024-03-31 | View |
| 8-K | 2024-05-14 | — | View |
| 8-K | 2024-05-01 | 2024-04-26 | View |
| 8-K | 2024-03-27 | — | View |
| 10-K | 2024-03-27 | 2023-12-31 | View |
| 8-K | 2024-02-13 | — | View |